Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Apr;8(4):11–20.

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

PMC Copyright notice

Figure 4. — Subjects treated for 12 months with bimatoprost (Bim), whose changes in eyelash length and eyelash thickness approximated the median percentage changes for the population with chemotherapy-induced eyelash hypotrichosis receiving bimatoprost during both study periods.

A) Eyelash length in a subject from the Bim/Bim group at baseline (4.5mm), 6 months (36.7% increase from baseline), and 12 months (36.7% increase from baseline). Top: Baseline length = 4.5mm. Median length at baseline for Bim/Bim postchemotherapy group = 4.80mm. Middle: Month 6 percent increase from baseline length = 36.67%. Median percent change from baseline to Month 6 for Bim/Bim postchemotherapy group = 37.84%. Bottom: Month 12 percent increase from baseline length = 36.67%. Median percent change from baseline to Month 12 for Bim/Bim postchemotherapy group = 39.08%.

B) Eyelash thickness in a subject from the Bim/Bim group at baseline (0.30 mm²), 6 months (266.7% increase from baseline), and 12 months (200.0% increase from baseline). Top: Baseline thickness = 0.30mm². Median thickness at baseline for Bim/Bim postchemotherapy group = 0.3 mm². Middle: Month 6 percent increase from baseline thickness = 266.7%. Median percent change from baseline to Month 6 for Bim/Bim postchemotherapy group = 245.0%. Bottom: Month 12 percent increase from baseline thickness = 200.0%. Median percent change from baseline to Month 12 for Bim/Bim postchemotherapy group = 211.8%.

Figure 4. — Subjects treated for 12 months with bimatoprost (Bim), whose changes in eyelash length and eyelash thickness approximated the median percentage changes for the population with chemotherapy-induced eyelash hypotrichosis receiving bimatoprost during both study periods.

A) Eyelash length in a subject from the Bim/Bim group at baseline (4.5mm), 6 months (36.7% increase from baseline), and 12 months (36.7% increase from baseline). Top: Baseline length = 4.5mm. Median length at baseline for Bim/Bim postchemotherapy group = 4.80mm. Middle: Month 6 percent increase from baseline length = 36.67%. Median percent change from baseline to Month 6 for Bim/Bim postchemotherapy group = 37.84%. Bottom: Month 12 percent increase from baseline length = 36.67%. Median percent change from baseline to Month 12 for Bim/Bim postchemotherapy group = 39.08%.

B) Eyelash thickness in a subject from the Bim/Bim group at baseline (0.30 mm²), 6 months (266.7% increase from baseline), and 12 months (200.0% increase from baseline). Top: Baseline thickness = 0.30mm². Median thickness at baseline for Bim/Bim postchemotherapy group = 0.3 mm². Middle: Month 6 percent increase from baseline thickness = 266.7%. Median percent change from baseline to Month 6 for Bim/Bim postchemotherapy group = 245.0%. Bottom: Month 12 percent increase from baseline thickness = 200.0%. Median percent change from baseline to Month 12 for Bim/Bim postchemotherapy group = 211.8%.